ENG mutational mosaicism in a family with hereditary hemorrhagic telangiectasia

ENG mutational mosaicism in a family with hereditary hemorrhagic telangiectasia INTRODUCTIONHereditary hemorrhagic telangiectasia (HHT), also known as Osler–Weber–Rendu disease, is an autosomal dominant hereditary disorder characterized by a variety of clinical manifestations due to the presence of multiple mucocutaneous telangiectases and arteriovenous malformations (AVMs) in internal organs, most commonly lungs, liver, and cerebrum. The most frequent clinical manifestation is spontaneous and recurrent epistaxis, affecting more than 95% of all HHT patients. Pulmonary arteriovenous malformations (PAVMs) are observed in about one‐third of all HHT patients (Kjeldsen, Oxhøj, Andersen, Green, & Vase, ), and can cause cerebral abscess or stroke due to paradoxical embolism (Kjeldsen et al., ; Mathis et al., ). Cerebral AVMs are present in at least 10% of HHT patients and hepatic AVMs are common, but rarely symptomatic (Dupuis‐Girod, Bailly, & Plauchu, ; Faughnan et al., ).HHT is a genetically heterogeneous disorder caused by mutations in three known genes: ENG (OMIM 131195), ACVRL1 (OMIM 601284), and SMAD4 (OMIM 600993).HHT is a clinical diagnosis, according to the Curaçao criteria (Shovlin et al., ). In approximately 85% of the HHT patients a mutation in either ENG or ACVRL1 (Torring, Brusgaard, Ousager, Andersen, & Kjeldsen, ) can be identified at mutation analysis. Only around 2% of HHT patients have mutations in SMAD4 (Gallione et al., , http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Molecular Genetics & Genomic Medicine Wiley

ENG mutational mosaicism in a family with hereditary hemorrhagic telangiectasia

Loading next page...
 
/lp/wiley/eng-mutational-mosaicism-in-a-family-with-hereditary-hemorrhagic-bEYe4VLsuk
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 John Wiley & Sons Ltd.
ISSN
2324-9269
eISSN
2324-9269
D.O.I.
10.1002/mgg3.361
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONHereditary hemorrhagic telangiectasia (HHT), also known as Osler–Weber–Rendu disease, is an autosomal dominant hereditary disorder characterized by a variety of clinical manifestations due to the presence of multiple mucocutaneous telangiectases and arteriovenous malformations (AVMs) in internal organs, most commonly lungs, liver, and cerebrum. The most frequent clinical manifestation is spontaneous and recurrent epistaxis, affecting more than 95% of all HHT patients. Pulmonary arteriovenous malformations (PAVMs) are observed in about one‐third of all HHT patients (Kjeldsen, Oxhøj, Andersen, Green, & Vase, ), and can cause cerebral abscess or stroke due to paradoxical embolism (Kjeldsen et al., ; Mathis et al., ). Cerebral AVMs are present in at least 10% of HHT patients and hepatic AVMs are common, but rarely symptomatic (Dupuis‐Girod, Bailly, & Plauchu, ; Faughnan et al., ).HHT is a genetically heterogeneous disorder caused by mutations in three known genes: ENG (OMIM 131195), ACVRL1 (OMIM 601284), and SMAD4 (OMIM 600993).HHT is a clinical diagnosis, according to the Curaçao criteria (Shovlin et al., ). In approximately 85% of the HHT patients a mutation in either ENG or ACVRL1 (Torring, Brusgaard, Ousager, Andersen, & Kjeldsen, ) can be identified at mutation analysis. Only around 2% of HHT patients have mutations in SMAD4 (Gallione et al., ,

Journal

Molecular Genetics & Genomic MedicineWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off